Table 1.

Patients were treated in four cohorts

Cohort	Antigen expression by IHC	Lymphodepletion regimen
1	2+ or 3+ in ≥50% of tumor cells	Flu 30 mg/m2/d × 4 + Cy 1800 mg/m2/d × 2
2	>  1+ in > 1% but < 2+ or 3+ in ≥50% of tumor cells	Flu 30 mg/m2/d × 4 + Cy 1800 mg/m2/d × 2
3	2+ or 3+ in ≥50% of tumor cells	Cy 1800 mg/m2/d × 2
4	2+ or 3+ in ≥50% of tumor cells	Flu 30 mg/m2/d × 3 + Cy 600 mg/m2/d × 3